Tag archive
A new AI pipeline claims to halve diagnosis time for rare diseases. I dug into the data, patient experiences, and the tech behind the Rare Disease Data Center t
Data centers promise rare disease breakthroughs, but they lag behind. I reveal why traceable reasoning and agentic systems deliver faster, verifiable diagnoses.
Federated learning requires large cohorts at each site to compute stable gradients. Rare disease research does not have large cohorts. QIS outcome routing imposes no minimum cohort size — every validated treatment outcome routes, regardless of N. Here is how.
A child has been through 14 institutions in 6 years. Every specialist has run their own panel. No one...